Lexeo Therapeutics(LXEO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LXEO Lexeo Therapeutics

劳工日休市 09-04 16:00:00 EDT

4.89

+0.05

+1.03%

盘后4.89

+0.000.00%

19:30 EDT

最高4.99	最低4.76	成交量29.64万
今开4.76	昨收4.84	日振幅4.75%
总市值4.01亿	流通市值2.51亿	总股本8,205万
成交额145.17万	换手率0.58%	流通股本5,123万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LXEO","market":"US","secType":"STK","nameCN":"Lexeo Therapeutics","latestPrice":4.89,"timestamp":1788552000000,"preClose":4.84,"halted":0,"volume":296442,"hourTrading":{"tag":"盘后","latestPrice":4.89,"preClose":4.89,"latestTime":"19:30 EDT","volume":2555,"amount":12493.95,"timestamp":1788564603388,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.010330578512396658,"floatShares":51229500,"shares":82046255,"eps":-1.145694,"marketStatus":"劳工日休市","change":0.05,"latestTime":"09-04 16:00:00 EDT","open":4.76,"high":4.99,"low":4.76,"amount":1451694.9423366,"amplitude":0.047521,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.145694,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1698984000000,"exchange":"NASDAQ","adjPreClose":4.84,"preHourTrading":{"tag":"盘前","latestPrice":4.77,"preClose":4.84,"latestTime":"09:29 EDT","volume":303,"amount":1450.7600610000002,"timestamp":1788528599999,"change":-0.07,"changeRate":-0.014463,"amplitude":0.152893},"postHourTrading":{"tag":"盘后","latestPrice":4.89,"preClose":4.89,"latestTime":"19:30 EDT","volume":2555,"amount":12493.95,"timestamp":1788564603388,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6340134681512412,"impliedVol":0.2172,"impliedVolPercentile":0.0278},"requestUrl":"/m/hq/s/LXEO","defaultTab":"news","newsList":[{"id":"1182515272","title":"Lexeo Therapeutics旗下LX2020获FDA再生医学先进疗法认定，用于治疗PKP2致心律失常性心肌病","url":"https://stock-news.laohu8.com/highlight/detail?id=1182515272","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182515272?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:02","pubTimestamp":1785927758,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics宣布，其针对PKP2致心律失常性心肌病（PKP2 ACM）的候选药物LX2020，已获得美国食品药品监督管理局（FDA）授予的再生医学先进疗法（RMAT）认定。这一里程碑式的进展，为该创新疗法在罕见心脏病领域的研发注入了强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172946519","title":"Lexeo Therapeutics 公布 Lx2006 基因疗法治疗弗里德赖希共济失调的监管进展与注册性试验设计","url":"https://stock-news.laohu8.com/highlight/detail?id=1172946519","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172946519?lang=zh_cn&edition=full","pubTime":"2026-06-15 19:06","pubTimestamp":1781521615,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics 近日宣布了其针对弗里德赖希共济失调的 Lx2006 基因疗法的监管更新与注册性试验设计。这一进展标志着该疗法向临床验证与未来可能的商业化应用迈出了关键一步。公司详细阐述了试验方案的核心要素与监管沟通的成果，旨在加速这一潜在创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144505947","title":"Lexeo Therapeutics - Sunrise-Fa 2项目启动按计划推进，目标2026年第二季度，首例患者预计六月末入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1144505947","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144505947?lang=zh_cn&edition=full","pubTime":"2026-06-15 19:05","pubTimestamp":1781521516,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics公司宣布，其Sunrise-Fa 2项目的启动工作正按计划稳步推进，目标是在2026年第二季度内完成。公司预计，首例患者将在今年六月底前入组。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517164501","title":"Lexeo Therapeutics, Inc.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517164501?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:37","pubTimestamp":1741275437,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时37分，Lexeo Therapeutics, Inc.股票出现异动，股价快速上涨5.52%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306233717989ec1c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306233717989ec1c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630560","title":"Lexeo Therapeutics, Inc.盘中异动 早盘急速跳水5.59%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630560?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:09","pubTimestamp":1741014544,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时09分，Lexeo Therapeutics, Inc.股票出现波动，股价大幅下挫5.59%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1229.48%、127.25%、104.27%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230904989a1a96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230904989a1a96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514081320","title":"Lexeo Therapeutics, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514081320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514081320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Lexeo Therapeutics, Inc.股票出现波动，股价快速拉升5.18%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Enveric Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Virpax Pharmaceuticals, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为481.31%、239.37%、56.19%，振幅较大的相关个股有Spyre Therapeutics, Inc.、Trevi Therapeutics, Inc.、Aditxt, Inc.，振幅分别为8.03%、7.11%、6.64%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223146abe0ea5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223146abe0ea5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514085472","title":"Lexeo Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514085472?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:17","pubTimestamp":1740583041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时17分，Lexeo Therapeutics, Inc.股票出现异动，股价快速跳水5.19%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Athira Pharma, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5009.26%、179.49%、158.89%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Organovo Holdings, Inc.，振幅分别为161.02%、39.47%、33.94%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720638","title":"Lexeo Therapeutics, Inc.盘中异动 股价大跌5.40%报3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720638?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408503,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Lexeo Therapeutics, Inc.股票出现异动，股价大幅下挫5.40%。截至发稿，该股报3.68美元/股，成交量9305股，换手率0.03%，振幅5.91%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224823962e9d13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224823962e9d13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXEO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512472167","title":"Lexeo Therapeutics, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512472167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512472167?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:03","pubTimestamp":1739898197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时03分，Lexeo Therapeutics, Inc.股票出现波动，股价快速下跌5.33%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为463.15%、183.70%、154.75%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010317988a167f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010317988a167f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXEO","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511522085","title":"Lexeo Therapeutics, Inc.盘中异动 早盘急速上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511522085?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:10","pubTimestamp":1739463053,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时10分，Lexeo Therapeutics, Inc.股票出现异动，股价快速拉升5.57%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Moleculin Biotech, Inc.较为活跃，换手率分别为2682.83%、1164.82%、939.61%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为454.76%、95.15%、92.30%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140010539621d0d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140010539621d0d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380317","title":"Lexeo Therapeutics, Inc.盘中异动 早盘股价大涨6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380317?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:38","pubTimestamp":1739284732,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时38分，Lexeo Therapeutics, Inc.股票出现异动，股价快速拉升6.27%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2205.35%、565.96%、216.19%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为31.80%、29.73%、25.49%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112238529881be5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112238529881be5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509200531","title":"Lexeo Therapeutics, Inc.盘中异动 下午盘股价大跌5.25%报5.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509200531?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:27","pubTimestamp":1738866469,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时27分，Lexeo Therapeutics, Inc.股票出现异动，股价大幅下跌5.25%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022749abc5038a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022749abc5038a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXEO","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509872512","title":"Lexeo Therapeutics, Inc.盘中异动 早盘股价大跌5.55%报5.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509872512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509872512?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:05","pubTimestamp":1738767950,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时05分，Lexeo Therapeutics, Inc.股票出现异动，股价快速下跌5.55%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3726.79%、1097.12%、663.42%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为59.80%、58.93%、54.05%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523055096190f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523055096190f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507543057","title":"Lexeo Therapeutics, Inc.盘中异动 临近午盘快速跳水5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507543057?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:32","pubTimestamp":1738081928,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时32分，Lexeo Therapeutics, Inc.股票出现波动，股价快速跳水5.45%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129003209a232878e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129003209a232878e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505553861","title":"Lexeo Therapeutics, Inc.盘中异动 早盘快速跳水6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505553861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505553861?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:31","pubTimestamp":1737729060,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时31分，Lexeo Therapeutics, Inc.股票出现异动，股价快速跳水6.42%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为1976.01%、1103.67%、834.45%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.，振幅分别为11.80%、8.91%、6.18%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223100960f8d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223100960f8d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505047482","title":"Lexeo Therapeutics, Inc.盘中异动 下午盘股价大涨5.71%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505047482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505047482?lang=zh_cn&edition=full","pubTime":"2025-01-24 02:51","pubTimestamp":1737658295,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日02时51分，Lexeo Therapeutics, Inc.股票出现波动，股价快速上涨5.71%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Nutriband Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6361.36%、3915.06%、698.54%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为948.57%、145.99%、84.55%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124025135960e742e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124025135960e742e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXEO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505721544","title":"Lexeo Therapeutics, Inc.盘中异动 急速拉升5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505721544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505721544?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:49","pubTimestamp":1737557393,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时49分，Lexeo Therapeutics, Inc.股票出现异动，股价快速上涨5.53%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Immunoprecise Antibodies Ltd.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为601.50%、125.18%、58.35%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts 、Marker Therapeutics, Inc.，振幅分别为36.45%、23.26%、18.99%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122224953abb4aa65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122224953abb4aa65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXEO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504719095","title":"Lexeo Therapeutics, Inc.盘中异动 下午盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504719095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504719095?lang=zh_cn&edition=full","pubTime":"2025-01-18 02:23","pubTimestamp":1737138220,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日02时23分，Lexeo Therapeutics, Inc.股票出现波动，股价急速跳水5.59%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118022340a225ef22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118022340a225ef22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503624740","title":"Lexeo Therapeutics, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503624740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503624740?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:43","pubTimestamp":1736959438,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时43分，Lexeo Therapeutics, Inc.股票出现异动，股价大幅跳水5.17%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116004358abac112c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116004358abac112c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501177647","title":"Lexeo Therapeutics, Inc.盘中异动 早盘大幅下跌5.05%报6.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501177647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501177647?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:53","pubTimestamp":1736348017,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时53分，Lexeo Therapeutics, Inc.股票出现异动，股价大幅跳水5.05%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822533795fd038a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822533795fd038a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexeotx.com","stockEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":0.0989},{"period":"3month","weight":0.119},{"period":"6month","weight":-0.2861},{"period":"1year","weight":-0.0161},{"period":"ytd","weight":-0.5076}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexeo Therapeutics, Inc.成立于2017年2月17日，是根据特拉华州法律成立的有限责任公司，法定名称为Lexeo Therapeutics, LLC。该公司于2020年11月20日将有限责任公司转换为特拉华州的Lexeo Therapeutics, Inc.。该公司是一家临床阶段的基因医学公司，致力于通过应用开创性的科学从根本上改变疾病的治疗方式来改变医疗保健。该公司最先进的心血管候选产品LX2006用于治疗弗里德赖希共济失调（简称FA）心肌病患者，目前正在进行一项正在进行的1/2期临床试验。该公司第二先进的心血管候选产品LX2020用于治疗由PKP2基因突变引起的致心律失常心肌病，简称PKP2-ACM，于2023年7月获得美国食品药品监督管理局（FDA）的IND批准。","exchange":"NASDAQ","name":"Lexeo Therapeutics","nameEN":"Lexeo Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lexeo Therapeutics(LXEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lexeo Therapeutics(LXEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lexeo Therapeutics,LXEO,Lexeo Therapeutics股票,Lexeo Therapeutics股票老虎,Lexeo Therapeutics股票老虎国际,Lexeo Therapeutics行情,Lexeo Therapeutics股票行情,Lexeo Therapeutics股价,Lexeo Therapeutics股市,Lexeo Therapeutics股票价格,Lexeo Therapeutics股票交易,Lexeo Therapeutics股票购买,Lexeo Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lexeo Therapeutics(LXEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lexeo Therapeutics(LXEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}